In the first trial with human subjects, it reduced the number of immune system 'killer' cells that attack crucial insulin-producing cells, study shows.
A "reverse vaccine" that allows people with Type 1 diabetes to produce their own insulin has passed its first test with human subjects, according to a new study. The success points to a potential new strategy for treating those in the early stages of the disease, experts said.
via L.A. Times - Health http://feeds.latimes.com/~r/latimes/features/health/~3/VscchmdGX0U/la-sci-diabetes-reverse-vaccine-20130627,0,5414268.story
A "reverse vaccine" that allows people with Type 1 diabetes to produce their own insulin has passed its first test with human subjects, according to a new study. The success points to a potential new strategy for treating those in the early stages of the disease, experts said.
via L.A. Times - Health http://feeds.latimes.com/~r/latimes/features/health/~3/VscchmdGX0U/la-sci-diabetes-reverse-vaccine-20130627,0,5414268.story
No comments:
Post a Comment